Stockholm, January 24, 2023 - Intervacc’s Chief Scientific Officer Dr Andrew Waller will talk about the prevention of equine strangles at the Federation of European Equine Veterinary Associations (FEEVA) European Horse ... Read more
Stockholm, January 23, 2023 - The 17th edition of the Veterinary Sport Horse Congress in Amsterdam which attracts veterinarians from all over the globe, is an opportunity for attendees to learn about the latest research ... Read more
Stockholm, December 19th, 2022 - Intervacc AB (publ) and the Swedish University of Agricultural Sciences, SLU, announce today that they have extended the contract for the development of animal health vaccines using ... Read more
Stockholm, December 13th, 2022 - Intervacc AB (publ) announces today that the first batch of Strangvac®, a vaccine against the highly contagious bacterial equine disease Strangles, has been released for sale ... Read more
Stockholm, November 28, 2022 – Intervacc AB (publ) announces today that Strangvac® is now available for sale in Poland. Dechra Pharmaceuticals PLC distributes the vaccine in Poland and in a number of other ... Read more